These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33448442)

  • 1. Validating the visceral sensitivity index in an eating disorder sample.
    Brown TA; Reilly EE; Murray HB; Perry TR; Kaye WH; Wierenga CE
    Int J Eat Disord; 2021 Jun; 54(6):986-994. PubMed ID: 33448442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal-Specific symptom anxiety in patients with gastroparesis: Relationships to symptom severity and quality of life.
    Tanner SE; Burton Murray H; Brown TA; Malik Z; Parkman HP
    Neurogastroenterol Motil; 2023 May; 35(5):e14534. PubMed ID: 36740788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.
    Labus JS; Mayer EA; Chang L; Bolus R; Naliboff BD
    Psychosom Med; 2007 Jan; 69(1):89-98. PubMed ID: 17244851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety.
    Lalouni M; Olén O; Bjureberg J; Bonnert M; Chalder T; Hedman-Lagerlöf E; Reme SE; Serlachius E; Ljótsson B
    Acta Paediatr; 2022 Aug; 111(8):1621-1627. PubMed ID: 35545865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
    Trieschmann K; Chang L; Park S; Naliboff B; Joshi S; Labus JS; Sauk JS; Limketkai BN; Mayer EA
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14384. PubMed ID: 35478469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students.
    Saigo T; Tayama J; Hamaguchi T; Nakaya N; Tomiie T; Bernick PJ; Kanazawa M; Labus JS; Naliboff BD; Shirabe S; Fukudo S
    Biopsychosoc Med; 2014 Mar; 8(1):10. PubMed ID: 24655428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eating Disorder-15 (ED-15): Factor structure, psychometric properties, and clinical validation.
    Rodrigues T; Vaz AR; Silva C; Conceição E; Machado PPP
    Eur Eat Disord Rev; 2019 Nov; 27(6):682-691. PubMed ID: 31257707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor structure and psychometric properties of a multicultural Spanish-language version of the Eating Disorder-15 in a nonclinical sample of Chilean women.
    Compte EJ; Cruzat-Mandich C; Pérez Ríos L; Vásquez S; Gómez N; Trujillo-ChiVacuan E
    Int J Eat Disord; 2023 Apr; 56(4):727-735. PubMed ID: 36416591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender norms, psychometric properties, and validity for the Eating Pathology Symptoms Inventory.
    Forbush KT; Wildes JE; Hunt TK
    Int J Eat Disord; 2014 Jan; 47(1):85-91. PubMed ID: 23996154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Portuguese version of the Clinical Impairment Assessment (CIA) in eating disorders' patients.
    Vaz AR; Conceição E; Pinto-Bastos A; Silva D; Machado PPP
    Eat Weight Disord; 2020 Jun; 25(3):627-635. PubMed ID: 30838511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety-related factors associated with symptom severity in irritable bowel syndrome.
    Black CJ; Yiannakou Y; Houghton LA; Shuweihdi F; West R; Guthrie E; Ford AC
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13872. PubMed ID: 32396247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation, confirmatory factor analysis, and psychometric properties of the Brazilian version of the Repetitive Eating Questionnaire.
    Teodoro MC; Conceição EM; Sinval J; de Lourdes M; Neufeld CB
    Int J Eat Disord; 2023 Apr; 56(4):747-757. PubMed ID: 36965138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmatory factor analysis and measurement invariance of the Cognitive Fusion Questionnaire-Body Image in a clinical eating disorder sample.
    Barney JL; Barrett TS; Lensegrav-Benson T; Quakenbush B; Twohig MP
    Body Image; 2021 Sep; 38():262-269. PubMed ID: 34000498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor structure and construct validity of the Eating Disorder Examination-Questionnaire in college students: further support for a modified brief version.
    Grilo CM; Reas DL; Hopwood CJ; Crosby RD
    Int J Eat Disord; 2015 Apr; 48(3):284-9. PubMed ID: 25346071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders.
    Wisting L; Johnson SU; Bulik CM; Andreassen OA; Rø Ø; Bang L
    BMC Psychiatry; 2021 Jan; 21(1):6. PubMed ID: 33402149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the eating disorder fear questionnaire and interview: Preliminary investigation of eating disorder fears.
    Levinson CA; Vanzhula IA; Christian C
    Eat Behav; 2019 Dec; 35():101320. PubMed ID: 31445189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Experiences in Close Relationships Scale-12: Attachment dimensions in a clinical sample with eating disorders.
    Tasca GA; Brugnera A; Baldwin D; Carlucci S; Compare A; Balfour L; Proulx G; Gick M; Lafontaine MF
    Int J Eat Disord; 2018 Jan; 51(1):18-27. PubMed ID: 29215748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmatory factor analysis and psychometric properties of the Yale-Brown-Cornell Eating Disorders Scale Self-Report version (SR-YBC-EDS) in Spanish clinical and non-clinical samples.
    Perpiñá C; Giraldo-O'Meara M; Roncero M; Martínez-Gómez M
    Eat Behav; 2015 Apr; 17():6-9. PubMed ID: 25528716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials.
    Longstreth GF; Bolus R; Naliboff B; Chang L; Kulich KR; Carlsson J; Mayer EA; Naesdal J; Wiklund IK
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):411-20. PubMed ID: 15756093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.
    Labus JS; Bolus R; Chang L; Wiklund I; Naesdal J; Mayer EA; Naliboff BD
    Aliment Pharmacol Ther; 2004 Jul; 20(1):89-97. PubMed ID: 15225175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.